TARGEAR
Targeting challenges of active ageing: innovative integrated strategies for the healing of age-related hearing loss
| Coordinatore | AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Organization address
address: CALLE SERRANO 117 contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 1˙341˙405 € |
| EC contributo | 1˙341˙405 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2013-IAPP |
| Funding Scheme | MC-IAPP |
| Anno di inizio | 2014 |
| Periodo (anno-mese-giorno) | 2014-01-01 - 2017-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Organization address
address: CALLE SERRANO 117 contact info |
ES (MADRID) | coordinator | 383˙721.66 |
| 2 |
AFFICHEM SA
Organization address
address: RUE SAINT JOSEPH 9 contact info |
FR (TOULOUSE) | participant | 431˙258.20 |
| 3 |
MED-EL Elektromedizinische Geraete GmbH
Organization address
address: FUERSTENWEG 77a contact info |
AT (Innsbruck) | participant | 293˙452.90 |
| 4 |
UNIVERSITA DEGLI STUDI DI FIRENZE
Organization address
address: Piazza San Marco 4 contact info |
IT (Florence) | participant | 170˙109.06 |
| 5 |
USTAV EXPERIMENTALNI MEDICINY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE
Organization address
address: VIDENSKA 1083 contact info |
CZ (PRAHA 4) | participant | 62˙863.36 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Worldwide, 278 million people are estimated to have moderate to profound hearing loss. Age-related hearing loss, also known as presbyacusis, affects approximately half of the population over 60 years old, making it the second most common cause of disability in older people. There is no restorative treatment for deafness but functional replacement by means of prosthesis. Therefore, prevention and treatment of hearing loss is an unmet medical need. The TARGEAR project is constituted by experienced research groups in complementary fields ranging from the molecular to the clinical aspects of age-related hearing loss. The general objective is to develop a collaborative strategy between public research centres and private companies, based in transfer of knowledge, to design and implement preclinical studies for presbyacusis. A second general objective is to contribute to the formation of early-stage researchers in the experimental design, transfer and translation of knowledge in the field of hearing loss. It is essential for Europe future aged population to have well-trained people available to understand hearing loss from a general perspective. According to this, the foreseen secondments and training activities will involve a total of 15 experienced and early-stage researchers. In the end, TARGEAR project will develop a stronger biomedical research in hearing loss for a better future for the deaf people.'